Research - Melbourne, Victoria, Australia
Myopharm is a clinical stage, biotechnology company focused on developing first in class therapeutic products for the treatment and prevention of diabetes. Myopharm is currently developing a number of diabetes assets, including Omni - D for pharmacy channel launching early 2023.
Gmail
Amazon CloudFront
Amazon Elastic Load Balancer
Route 53
Google Apps
Amazon AWS